retatrutide clinical trials us Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS News investigation found. @adamyamaguchi Retatrutide Dosing: Early Clinical Trial
Description
Chronic stress can do the same via cortisol
Some orthopedic surgeons may perceive the growing use of GLP-1 receptor agonists as a potential threat to their practice, fearing that widespread weight loss could reduce the volume of patients requiring joint replacements
GLP-1 drugs like Ozempic deliver huge weight loss but new research reveals a hidden catch GLP-1 drugs like Mounjaro, Ozempic, and Wegovy offer powerful weight loss but come with big unknowns that demand independent study
LaFata et al., 2025) and such a pattern of food-intake behavior closely mirrors the compulsive consumption observed in drug addiction, where people are unable to abstain or moderate usage despite recognizing the associated risks (DSM-V, 2013)
Who should consider orforglipron
The GLP-1 is a metabolic support ketone shot designed for people navigating appetite patterns, fasting windows, or mid day energy dips
